Replies to post #260318 on Amarin Corp Plc (AMRN)

[massulo52]

Hopefully they turn the their option chain off!!!!!

[eboomer2611]

IMPORTANT Quick Question. We keep talking about TEVA as the big threat from generics. But if memory serves, doesnt TEVA if they patents get invalidated and they launch early have to pay AMRN a royalty on their sales? So in a generic competition world we would have the sales that we cn maintain, but wouldnt TEVA with generic Lovaza move over those sales plus be the most dominant generic and we would get a royalty from them which would all drop to the bottom line and also could theoretically allow us to subsidize reducing our own costs. Am I missing something